Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma

Annals of Oncology

Volumn 8, Issue SUPPL. 2, 1997, Pages

  Matolcsy, A ^a   Warnke, R A ^b   Knowles, D M ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

bcl 2 oncogene; Diffuse large cell lymphoma; Follicular lymphoma; Lymphoma transformation; Somatic mutation

Indexed keywords

AMINO ACID; DNA; GENE PRODUCT; IMMUNOGLOBULIN HEAVY CHAIN;

CHROMOSOME ABERRATION; CONFERENCE PAPER; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; ONCOGENE; OPEN READING FRAME; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 0030749757     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_2.S119     Document Type: Conference Paper

References (13)

1. Garvin AJ, Simon RM, Osborne CK et al. An autopsy study of histologic progresssion in non-Hodgkin's lymphomas: 192 cases from the National Cancer Institute. Cancer 1983; 52: 393-405.
2. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82: 7439-43.
3. Cleary ML, Galili N, Sklar J. Detection of a second t(14;18) break-point cluster region in human follicular lymphomas. J Exp Med 1986; 164: 315-20.
4. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: Regulations of cell death. Blood 1992; 80: 879-86.
5. Richardson ME, Quanguang C, Filippa DA et al. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood 1987; 70: 444-7.
6. Yano T, Jaffe ES, Longo DL et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758-67.
7. Lo Coco F, Gaidano G, Louie DC et al. P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-95.
8. Crescenzi M, Seto M, Herzig GP et al. Thermostable DNA polymerase chain amplification of 1(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988; 85: 4869-73.
9. Tanaka S, Kant J, Reed JC. G to A polymorphism in the second exon of the bcl-2 gene. Nucleic Acid Res 1991; 19: 1964-9.
10. Seto M, Jaeger U, Hockett RD et al. Alternative promoters and exons, somatic mutation, and transcriptional deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 1988; 7: 123-9.
11. Tanaka S, Louie DC. Kant JA et al. Frequent incidence of somatic mutations in translocated bcl-2 oncogenes of non-Hodgkin's lymphomas. Blood 1992; 79: 229-37.
12. Sato T, Hanada M, Bodrug S et al. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994; 91: 9238-42.
13. Yin X, Oltvai ZN, Korsmeyer SJ. HB1 and HB2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 1994; 369: 321-3.